Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies

Journal of Medical Virology

Volumn 60, Issue 2, 2000, Pages 133-138

  De Mitri, Maria Stella ^c   Mele, Loredana ^d   Morsica, Giulia ^a   Chen, Chiu Hua ^d   Sitia, Giovanni ^a   Gramenzi, Annagiulia ^d   Andreone, Pietro ^d   Alberti, Alfredo ^b   Bernardi, Mauro ^d   Pisi, Emilio ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NONE

Author keywords

Hepatitis C virus; Hypervariable region 1; Non structural 5A region; Single strand conformation polymorphism

Indexed keywords

INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; INTERFERON PRODUCTION; MALE; SINGLE STRAND CONFORMATION POLYMORPHISM; STRAIN DIFFERENCE; VIRUS MORPHOLOGY;

5' UNTRANSLATED REGIONS; ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

DNA VIRUSES; HEPATITIS C VIRUS; HEPATITIS C VIRUS TYPE 1;

EID: 18544406779     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200002)60:2<133::AID-JMV5>3.0.CO;2-Q     Document Type: Article

References (34)

1. Bukh J, Miller JH, Purcell RH. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41-63.
2. Carithers RL, Emerson SS. 1997. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 26(Suppl 1):83S-88S.
3. Chomczynsky P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
4. De Mitri MS, Mele L, Chen CH, Chianese R, Piccinini A, D'Errico A, Alberti A, Pisi E. 1998. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. J Hepatol 29:887-892.
5. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Brechot C, Paterlini P. 1995. HCV-associated liver cancer without cirrhosis. Lancet 345:413-415.
6. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortin J, Lopez-Galindez C, Perez-Brena P, Villanueva N, Najera R, VandePol S, Steinhauer D, DePolo N, Holland J. 1985. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance - a review. Gene 40:1-8.
7. Enomoto N, Kurosaki M, Yujiro T, Marumo F, Sato C. 1994. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 75:1361-1369.
8. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
9. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81.
10. Gale MJ, Korth MJ, Tang MN, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Greich DR, Katze MG. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by nonstructural 5A protein. Virology 230: 217-227.
11. Gonzalez-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JYN. 1996. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 49:242-247.
12. Houghton M, Weiner A, Han J, Kuo G, Choo QL. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
13. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara A, Fusamoto H, Kamada T. 1994. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 20: 1121-1130.
14. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotono K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sciences USA 87:9524-9528.
15. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron J-P, Lunel F, Stuyver L, Duverlie G. 1997. Mutations of hepatitis C virus 1b, NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferonalfa therapy in French patients. J Hepatol 27:72-77.
16. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C. 1995. Diversity of quasispecies in various disease stages of chronic hepatitis C infection and its significance in interferon treatment. Hepatology 22:30-35.
17. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522-7532.
18. Kurosaki M, Enomoto N, Marumo F, Sato C. 1993. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293-1299.
19. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
20. Lopez-Labrador F-X, Ampurdanes S, Gimenez-Barcons M, Guilera M, Costa J, Jimenez De Anta MT, Sanchez-Tapias JM, Rodes J, Saiz J-C. 1999. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection. Hepatology 29: 897-903.
21. Martell M, Esteban JI, Quer J, Genescà J, Weiner A, Esteban R, Guardia J, Gomez J. 1992. Hepatitis C (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225-3229.
22. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S. 1995. Pre-treatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
23. Moribe T, Hayashi N, Kanazawa Y, Mita E. Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Ukida K. 1995. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108:789-795.
24. Orita M, Suzuki Y, Sekyia T, Hayashi K. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
25. Pawlotsky JM, Pellerin M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Remire J, Soussy C-L, Dhumeaux D. 1998. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 54:256-264.
26. Polvak SJ, McArdle S, Liu S-L, Sullivan DG, Chung M, Hofgartner WT, Carithers RL, McMahon BJ, Mullins JI, Corey L, Gretch DR. 1998. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 72: 4288-4296.
27. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choc QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannia SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura M, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice G, Roggendorf M, Schalm SW, Shikata T, Shimothono K, Stuyver L, Trepò C, Weiner A, Yap PL, Urdea S. 1994. A proposed system for the nomenclature of hepatitis viral genotypes. Hepatology 19:1321-1324.
28. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Brechot C. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567-572.
29. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102.
30. Thompson JD, Higgins DG, Gibson TJ. 1994. Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
31. Tilg H. 1997. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112:1017-1021.
32. Tong MJ, El-Farra NS, Reikes AR, Co RL. 1995. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466.
33. Yano M, Hiromitsu K, Kage M, Ikeda K, Shimanatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K. 1996. The long term pathological evolution in chronic hepatitis C. Hepatology 23: 1334-1340.
34. Zeuzem S, Lee JH, Roth WK. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon-alfa. Hepatology 25:770-744.